{"filing": {"accession": "0001477932-26-003587", "cik": "0000093314", "ticker": "VNRX", "company_name": "VOLITIONRX LTD", "form_type": "DEF 14A", "filing_type": "DEF 14A", "filing_date": "2026-06-02", "accepted_datetime": null, "acceptance_datetime": null, "accepted_at": null, "primary_doc_url": "https://www.sec.gov/Archives/edgar/data/93314/000147793226003587/0001477932-26-003587-index.htm", "filing_url": "https://www.sec.gov/Archives/edgar/data/93314/000147793226003587/0001477932-26-003587-index.htm", "period_of_report": "2026-07-17"}, "html_url": "/api/filings/000147793226003587/stream", "exhibits": [], "sections": [], "tables": [{"table_index": 1, "table_type": "text", "caption": null, "header_text": "\u2610Preliminary Proxy Statement"}, {"table_index": 3, "table_type": "exhibit_index", "caption": null, "header_text": "\u2612No fee required."}, {"table_index": 10, "table_type": "text", "caption": null, "header_text": "5.Approval of 2026 Stock Incentive Plan.To approve the Company\u2019s 2026 Stock Incentive Plan; and"}, {"table_index": 11, "table_type": "text", "caption": null, "header_text": "By order of the Board of Directors"}, {"table_index": 13, "table_type": "exhibit_index", "caption": null, "header_text": "GENERAL INFORMATION1"}, {"table_index": 17, "table_type": "text", "caption": null, "header_text": "1.\u201cFOR\u201dthe election of each of the following seven director nominees: Dr. Phillip Barnes, Dr. Alan Colman, Guy Innes, Kim Nguyen, Cameron Reynolds, Dr. Ethel Rubin and Timothy Still to serve until the"}, {"table_index": 20, "table_type": "text", "caption": null, "header_text": "1.Election of Directors (Proposal 1). Directors are elected by a plurality of the voting power of the shares present in person or represented by proxy at the Annual Meeting and entitled to vote on the"}, {"table_index": 22, "table_type": "text", "caption": null, "header_text": "Name and Address of Beneficial OwnerAmount andNature ofBeneficial Ownership(#)Percent ofClass(1)(%)"}, {"table_index": 23, "table_type": "text", "caption": null, "header_text": "*Represents ownership of less than 1.0%"}, {"table_index": 25, "table_type": "text", "caption": null, "header_text": "(5)Ms. Henshall\u2019s beneficial ownership consists of direct ownership of 1,586 shares of common stock. Ms. Henshall will not be standing for re-election to our board of directors at the Annual Meeting."}, {"table_index": 27, "table_type": "text", "caption": null, "header_text": "NameAgePosition(s) with the CompanyOfficer/Director Since"}, {"table_index": 28, "table_type": "text", "caption": null, "header_text": "(1)Member of the Nominations and Governance Committee"}, {"table_index": 35, "table_type": "financial", "caption": null, "header_text": "\u00b7appointing, terminating, compensating and overseeing the work of any independent auditor engaged to prepare or issue an audit report or other audit, review or attest services;"}, {"table_index": 37, "table_type": "text", "caption": null, "header_text": "\u00b7developing, reviewing, and approving our overall compensation programs for directors and officers, and regularly reporting to the full board of directors regarding the adoption of such programs;"}, {"table_index": 39, "table_type": "text", "caption": null, "header_text": "\u00b7identifying and screening candidates for our board of directors, and recommending nominees for election as directors;"}, {"table_index": 43, "table_type": "exhibit_index", "caption": null, "header_text": "\u00b7engaging internal control consultants to assist us in performing a financial reporting risk assessment as well as identifying and designing our system of internal controls necessary to mitigate the r"}, {"table_index": 45, "table_type": "financial", "caption": null, "header_text": "\u00b7we have been or are to be a participant;"}, {"table_index": 49, "table_type": "text", "caption": null, "header_text": "Guy Innes, Chair"}, {"table_index": 51, "table_type": "text", "caption": null, "header_text": "Name and Principal PositionYearSalary($)Bonus($)StockAwards($)(1)All OtherCompensation($)Total($)"}, {"table_index": 52, "table_type": "text", "caption": null, "header_text": "(1)Amounts listed include the value of (i) granted performance-based restricted stock units not yet deemed earned; and (ii) restricted stock units granted in lieu of cash compensation that would other"}, {"table_index": 54, "table_type": "text", "caption": null, "header_text": "On June 1, 2024 and September 1, 2024, Dr. Michel was granted restricted stock unit awards for 684 shares of common stock and 784 shares of common stock of VolitionRx under the 2015 Plan, respectively"}, {"table_index": 58, "table_type": "text", "caption": null, "header_text": "Equity Incentive Plan Awards:Restricted Stock Units"}, {"table_index": 59, "table_type": "text", "caption": null, "header_text": "(1)The market value of unvested restricted stock unit awards as of December 31, 2025, is calculated by multiplying the number of shares subject to such awards by the closing price of our common stock "}, {"table_index": 61, "table_type": "text", "caption": null, "header_text": "(5)These restricted stock units were awarded on July 24, 2025, subject to vesting upon achievement of a closing stock price target above $50.00 per share of the Company\u2019s common stock for a minimum of"}, {"table_index": 63, "table_type": "text", "caption": null, "header_text": "NameGrantDateNumber ofSecuritiesUnderlyingUnexercisedOptions (#)ExercisableOptionExercisePrice($)OptionExpirationDate"}, {"table_index": 64, "table_type": "text", "caption": null, "header_text": "(1)On April 15, 2016, Mr. Reynolds was granted an option to purchase 6,250 shares of common stock of VolitionRx under the 2015 Plan, vesting in full on the 12-month anniversary of the date of grant. I"}, {"table_index": 66, "table_type": "financial", "caption": null, "header_text": "YearSummary CompensationTable Totalfor PEO(1)(2)CompensationActuallyPaid to PEO(1)(3)AverageSummary CompensationTable Totalfor Non-PEONEOs(2)(4)AverageCompensationActuallyPaid toNon-PEONEOs(3)(4)Value"}, {"table_index": 67, "table_type": "text", "caption": null, "header_text": "(1)Cameron Reynolds, our Chief Executive Officer, was our PEO for each year reported."}, {"table_index": 70, "table_type": "text", "caption": null, "header_text": "YearExecutivesSummary Compensation Table TotalDeductStockAwards Granted in CoveredYearDeductOption Awards Granted in CoveredYearAdd Year-End FairValue of Outstanding andUnvested EquityAwards Granted i"}, {"table_index": 71, "table_type": "financial", "caption": null, "header_text": "(4)The Non-PEO NEOs for each year reported were as follows:\u00b72025: Salvatore Thomas Butera and Dr. Gaetan Michel\u00b72024: Salvatore Thomas Butera and Dr. Gaetan Michel\u00b72023: Salvatore Thomas Butera and Dr"}, {"table_index": 76, "table_type": "text", "caption": null, "header_text": "Name of NomineeAgeDirector Since"}, {"table_index": 81, "table_type": "text", "caption": null, "header_text": "NameFeesEarnedor Paidin Cash($)StockAwards(1)($)All OtherCompensation($)Total($)"}, {"table_index": 82, "table_type": "exhibit_index", "caption": null, "header_text": "(1)Amounts listed include the value of granted performance-based restricted stock units not yet deemed earned; however, the amounts reported have been adjusted to exclude the grant date fair value of "}, {"table_index": 84, "table_type": "exhibit_index", "caption": null, "header_text": "(3)On March 31, 2015, Dr. Colman entered into an Independent Director Agreement with VolitionRx, or the Colman Independent Director Agreement, pursuant to which Dr. Colman will continue to serve as a "}, {"table_index": 86, "table_type": "exhibit_index", "caption": null, "header_text": "(6)On March 25, 2021, Ms. Nguyen entered into an Independent Director Agreement with VolitionRx, or the Nguyen Independent Director Agreement, pursuant to which Ms. Nguyen will continue to serve as a "}, {"table_index": 88, "table_type": "text", "caption": null, "header_text": "Year EndedDecember 31,2025Year EndedDecember 31,2024"}, {"table_index": 91, "table_type": "text", "caption": null, "header_text": "\u00b7Attract and retain key executives;"}, {"table_index": 92, "table_type": "text", "caption": null, "header_text": "\u00b7Including reasonable vesting provisions for our equity awards;"}, {"table_index": 96, "table_type": "text", "caption": null, "header_text": "Year Ended December 31,No. ofOptionsGrantedNo. ofSharesGranted(1)TotalGrantedWeightedAverageNo. of Shares ofCommon StockOutstandingAnnualBurnRate"}, {"table_index": 99, "table_type": "text", "caption": null, "header_text": "\u00b7Options.Options may be non-qualified stock options or incentive stock options and may vest based on time or achievement of performance goals. Our Compensation Committee may provide for options to be "}, {"table_index": 102, "table_type": "text", "caption": null, "header_text": "\u00b7permit the repricing of outstanding stock options or stock appreciation rights under the 2026 Plan;"}, {"table_index": 104, "table_type": "text", "caption": null, "header_text": "Plan categoryNumber ofsecuritiesto beissued uponexerciseof outstandingoptions,warrantsand rights (a)Weighted-averageexerciseprice ofoutstandingoptions,warrantsand rights (b)Number ofsecuritiesremainin"}, {"table_index": 105, "table_type": "text", "caption": null, "header_text": "(1)The weighted-average exercise price does not take into account 64,769 shares of common stock issuable upon vesting of outstanding restricted stock units, which have no exercise price."}, {"table_index": 111, "table_type": "text", "caption": null, "header_text": "By order of the Board of Directors,"}, {"table_index": 114, "table_type": "text", "caption": null, "header_text": "VOLITIONRX LIMITED"}], "exhibits_pending": true, "cdn_html": true, "response_time_ms": 36}